Jonathan C Fox - Net Worth and Insider Trading
Jonathan C Fox Net Worth
The estimated net worth of Jonathan C Fox is at least $101 Million dollars as of 2024-10-21. Jonathan C Fox is the Chief Medical Officer of MyoKardia Inc and owns about 239,190 shares of MyoKardia Inc (MYOK) stock worth over $54 Million. Jonathan C Fox is the See Remarks of Eidos Therapeutics Inc and owns about 380,967 shares of Eidos Therapeutics Inc (EIDX) stock worth over $47 Million. Jonathan C Fox is also the Director of Edgewise Therapeutics Inc and owns about 10,857 shares of Edgewise Therapeutics Inc (EWTX) stock worth over $386,183. Details can be seen in Jonathan C Fox's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jonathan C Fox has not made any transactions after 2023-12-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jonathan C Fox
Jonathan C Fox Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jonathan C Fox owns 3 companies in total, including Eidos Therapeutics Inc (EIDX) , MyoKardia Inc (MYOK) , and Edgewise Therapeutics Inc (EWTX) .
Click here to see the complete history of Jonathan C Fox’s form 4 insider trades.
Insider Ownership Summary of Jonathan C Fox
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
EIDX | Eidos Therapeutics Inc | 2020-09-17 | See Remarks |
MYOK | MyoKardia Inc | 2016-04-29 | Chief Medical Officer |
EWTX | Edgewise Therapeutics Inc | 2023-12-26 | director |
Jonathan C Fox Latest Holdings Summary
Jonathan C Fox currently owns a total of 3 stocks. Among these stocks, Jonathan C Fox owns 239,190 shares of MyoKardia Inc (MYOK) as of November 3, 2015, with a value of $54 Million and a weighting of 53.4%. Jonathan C Fox owns 380,967 shares of Eidos Therapeutics Inc (EIDX) as of September 17, 2020, with a value of $47 Million and a weighting of 46.22%. Jonathan C Fox also owns 10,857 shares of Edgewise Therapeutics Inc (EWTX) as of December 26, 2023, with a value of $386,183 and a weighting of 0.38%.
Latest Holdings of Jonathan C Fox
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MYOK | MyoKardia Inc | 2015-11-03 | 239,190 | 224.91 | 53,796,223 |
EIDX | Eidos Therapeutics Inc | 2020-09-17 | 380,967 | 122.21 | 46,557,977 |
EWTX | Edgewise Therapeutics Inc | 2023-12-26 | 10,857 | 35.57 | 386,183 |
Holding Weightings of Jonathan C Fox
Jonathan C Fox Form 4 Trading Tracker
According to the SEC Form 4 filings, Jonathan C Fox has made a total of 0 transactions in MyoKardia Inc (MYOK) over the past 5 years. The most-recent trade in MyoKardia Inc is the acquisition of 3,000 shares on November 3, 2015, which cost Jonathan C Fox around $30,000.
According to the SEC Form 4 filings, Jonathan C Fox has made a total of 13 transactions in Eidos Therapeutics Inc (EIDX) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Eidos Therapeutics Inc is the sale of 5,767 shares on September 17, 2020, which brought Jonathan C Fox around $289,273.
According to the SEC Form 4 filings, Jonathan C Fox has made a total of 1 transactions in Edgewise Therapeutics Inc (EWTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Edgewise Therapeutics Inc is the acquisition of 10,857 shares on December 26, 2023, which cost Jonathan C Fox around $100,970.
Insider Trading History of Jonathan C Fox
- 1
Jonathan C Fox Trading Performance
GuruFocus tracks the stock performance after each of Jonathan C Fox's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jonathan C Fox is 31.55%. GuruFocus also compares Jonathan C Fox's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jonathan C Fox within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jonathan C Fox's insider trading performs compared to the benchmark.
Performance of Jonathan C Fox
Jonathan C Fox Ownership Network
Jonathan C Fox Owned Company Details
What does Eidos Therapeutics Inc do?
Who are the key executives at Eidos Therapeutics Inc?
Jonathan C Fox is the See Remarks of Eidos Therapeutics Inc. Other key executives at Eidos Therapeutics Inc include director & Chief Scientific Officer Uma Sinha , Senior Vice President & Finance Franco Valle , and Chief Business Officer Cameron Turtle .
Eidos Therapeutics Inc (EIDX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eidos Therapeutics Inc (EIDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eidos Therapeutics Inc (EIDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eidos Therapeutics Inc (EIDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eidos Therapeutics Inc Insider Transactions
Jonathan C Fox Mailing Address
Above is the net worth, insider trading, and ownership report for Jonathan C Fox. You might contact Jonathan C Fox via mailing address: C/o Myokardia, Inc., 333 Allerton Avenue, South San Francisco Ca 94080.